Jennifer Taubert, J&J EVP, sells $3.95 million in Johnson & Johnson stock

Jennifer L. Taubert, the Executive Vice President and Worldwide Chairman of Innovative Medicine at Johnson & Johnson, made a substantial stock transaction on August 17, 2026. Ms. Taubert exercised her employee stock options to purchase 15,000 shares of company common stock. She then sold the same number of shares, earning an estimated $3.95 million from the sale.

Each option was granted under Johnson & Johnson's Long-Term Incentive Plan and could be exercised on the third anniversary of its grant date. The purchase price per share was $115.67, amounting to a total cost of $1,735,050. After exercising her options, Taubert sold 15,000 shares of Johnson & Johnson common stock. The shares were traded at a weighted average price of $263.36 per share, with individual trades between $263.30 and $263.48.

The proceeds from these sales reached $3,950,400. After these transactions, Taubert personally holds 194,451.001 shares of Johnson & Johnson common stock and still possesses 28,712 employee stock options.